Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long Interspersed Element 1 Reverse Transcriptase (None)
- Target
- None
- Molecular classification
- Enzyme, Reverse Transcriptase, Endonuclease
01
Overview
Long interspersed element 1 (LINE-1) reverse transcriptase is an enzyme encoded by the ORF2 region of LINE-1 retrotransposons. It catalyzes the synthesis of complementary DNA from its own mRNA template during retrotransposition, a process that involves copying RNA back into DNA and integrating it at new genomic locations. Aberrant activation of LINE-1 RT is implicated in cancer progression and genome instability, making it a potential therapeutic target.
- Other names
- LINE-1 RTL1 reverse transcriptaseORF2p
02
Mechanism of action
Inhibition of reverse transcriptase activity
03
Biological functions
cDNA synthesisTarget-primed reverse transcriptionRetrotranspositionGenomic integration
04
Disease associations
CancerInsertional mutagenesisGenome instability
05
Safety considerations
Potential for off-target effects on other reverse transcriptasesRisk of insertional mutagenesis if inhibition is incompleteDevelopment of resistance to inhibitors
06
Interacting drugs
Efavirenz
07
Biomarkers
LINE-1 mRNA expression levelsLINE-1 protein (ORF2p) levels
Beyond the preview
Go deeper on Long Interspersed Element 1 Reverse Transcriptase (None).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long Interspersed Element 1 Reverse Transcriptase (None).